- Home
- BDTX vs FLC Comparison
BDTX vs FLC Comparison
Compare BDTX & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- FLC
- Stock Information
- Founded
- BDTX 2014
- FLC 2003
- Country
- BDTX United States
- FLC United States
- Employees
- BDTX N/A
- FLC N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- FLC Trusts Except Educational Religious and Charitable
- Sector
- BDTX Health Care
- FLC Finance
- Exchange
- BDTX Nasdaq
- FLC Nasdaq
- Market Cap
- BDTX 220.3M
- FLC 178.9M
- IPO Year
- BDTX 2020
- FLC N/A
- Fundamental
- Price
- BDTX $3.84
- FLC $17.15
- Analyst Decision
- BDTX Strong Buy
- FLC
- Analyst Count
- BDTX 6
- FLC 0
- Target Price
- BDTX $10.17
- FLC N/A
- AVG Volume (30 Days)
- BDTX 1.1M
- FLC 37.8K
- Earning Date
- BDTX 11-06-2025
- FLC 01-01-0001
- Dividend Yield
- BDTX N/A
- FLC 6.64%
- EPS Growth
- BDTX N/A
- FLC N/A
- EPS
- BDTX 0.38
- FLC N/A
- Revenue
- BDTX $70,000,000.00
- FLC N/A
- Revenue This Year
- BDTX N/A
- FLC N/A
- Revenue Next Year
- BDTX N/A
- FLC N/A
- P/E Ratio
- BDTX $10.20
- FLC N/A
- Revenue Growth
- BDTX N/A
- FLC N/A
- 52 Week Low
- BDTX $1.20
- FLC $12.62
- 52 Week High
- BDTX $4.94
- FLC $15.45
- Technical
- Relative Strength Index (RSI)
- BDTX 46.51
- FLC 32.23
- Support Level
- BDTX $3.67
- FLC $17.05
- Resistance Level
- BDTX $4.06
- FLC $17.72
- Average True Range (ATR)
- BDTX 0.32
- FLC 0.14
- MACD
- BDTX -0.06
- FLC -0.04
- Stochastic Oscillator
- BDTX 13.95
- FLC 20.15
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.